These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 8493865)
1. Subacute panencephalitis associated with chronic graft-versus-host disease. Iwasaki Y; Sako K; Ohara Y; Miyazawa M; Minegishi M; Tsuchiya S; Konno T Acta Neuropathol; 1993; 85(5):566-72. PubMed ID: 8493865 [TBL] [Abstract][Full Text] [Related]
2. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. Spinelli S; Chiodi S; Costantini S; Van Lint MT; Raiola AM; Ravera GB; Bacigalupo A Haematologica; 2003 Oct; 88(10):1163-8. PubMed ID: 14555313 [TBL] [Abstract][Full Text] [Related]
3. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets. Gaschet J; Gallot G; Ibisch C; Lim A; Even J; Vivien R; Hallet MM; Milpied N; Vié H Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075 [TBL] [Abstract][Full Text] [Related]
4. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia. Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193 [TBL] [Abstract][Full Text] [Related]
5. Comparisons between allogeneic peripheral blood stem cell transplantation and allogeneic bone marrow transplantation in adult hematologic disease: a single center experience. Liu YC; Chang CS; Liu TC; Chen TP; Sue YC; Hsiao HH; Lin SF Kaohsiung J Med Sci; 2003 Nov; 19(11):541-8. PubMed ID: 14658482 [TBL] [Abstract][Full Text] [Related]
8. Selective CD4+ T-cell depletion does not prevent graft-versus-host disease. Nagler A; Condiotti R; Nabet C; Naparstek E; Or R; Samuel S; Slavin S Transplantation; 1998 Jul; 66(1):138-41. PubMed ID: 9679838 [TBL] [Abstract][Full Text] [Related]
9. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes. Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946 [TBL] [Abstract][Full Text] [Related]
10. Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies. Ringdén O; Remberger M; Carlens S; Hagglund H; Mattsson J; Aschan J; Lönnqvist B; Klaesson S; Winiarski J; Dalianis T; Olerup O; Sparrelid E; Elmhorn-Rosenborg A; Svahn BM; Ljungman P Transplantation; 1998 Sep; 66(5):620-5. PubMed ID: 9753343 [TBL] [Abstract][Full Text] [Related]
11. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia. Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255 [TBL] [Abstract][Full Text] [Related]
12. A case of chronic graft-versus-host-disease following allogeneic peripheral blood stem cell rescue for poor graft function after bone marrow transplantation. Kim HJ; Chung IJ; Lee JJ; Seo JS; Park MR; Choi KS; Kook H; Hwang TJ Korean J Intern Med; 1998 Feb; 13(1):60-3. PubMed ID: 9538634 [TBL] [Abstract][Full Text] [Related]
13. Graft-versus-host disease--clinical and pathological analysis of 11 biopsy proven cases. Kim KM; Han KJ; Kang CS; Shim SI J Korean Med Sci; 1994 Oct; 9(5):382-7. PubMed ID: 7702786 [TBL] [Abstract][Full Text] [Related]
14. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center]. van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502 [TBL] [Abstract][Full Text] [Related]
15. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies. Ostronoff F; Ostronoff M; Souto-Maior AP; Domingues M; Sucupira A; Manso DA; de Lima AK; Monteiro PG; Florêncio R; Calixto R Clin Transplant; 2009; 23(1):33-8. PubMed ID: 18727660 [TBL] [Abstract][Full Text] [Related]
17. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937 [TBL] [Abstract][Full Text] [Related]
18. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study. Bordigoni P; Esperou H; Souillet G; Pico J; Michel G; Lacour B; Reiffers J; Sadoun A; Rohrlich P; Jouet JP; Milpied N; Lutz P; Plouvier E; Cornu G; Vannier JP; Gandemer V; Rubie H; Gratecos N; Leverger G; Stephan JL; Boutard P; Vernant JP Br J Haematol; 1998 Aug; 102(3):656-65. PubMed ID: 9722290 [TBL] [Abstract][Full Text] [Related]
19. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate. Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856 [TBL] [Abstract][Full Text] [Related]
20. Possible clinical benefits of the use of peripheral blood stem cells over bone marrow in the allogeneic transplantation setting for the treatment of childhood leukemia. Matsubara H; Makimoto A; Takayama J; Higa T; Saito T; Kanda Y; Tanosaki R; Mineishi S; Ohira M; Takaue Y Jpn J Clin Oncol; 2001 Jan; 31(1):30-4. PubMed ID: 11256838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]